Listed

MiNK Therapeutics, Inc.

INKTNasdaqCIK 1840229HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$3.2m, Q2 FY2026
Net income−$3.1m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$k3,427Research and development, Q3 FY2023, three months to 2023-09-30$3.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0000950170-24-127033.Report this figure3,311Research and development, Q4 FY2023, three months to 2023-12-31$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-18, accession 0000950170-25-041379. Derived: 12-month figure less the 9-month figure.Report this figure2,549Research and development, Q1 FY2024, three months to 2024-03-31$2.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0000950170-25-072789.Report this figure1,840Research and development, Q2 FY2024, three months to 2024-06-30$1.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0000950170-25-108894.Report this figure541Research and development, Q3 FY2024, three months to 2024-09-30$540.6k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figure1,406Research and development, Q4 FY2024, three months to 2024-12-31$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001193125-26-134813. Derived: 12-month figure less the 9-month figure.Report this figure1,262Research and development, Q1 FY2025, three months to 2025-03-31$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001193125-26-226804.Report this figure1,839Research and development, Q2 FY2025, three months to 2025-06-30$1.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure1,143Research and development, Q3 FY2025, three months to 2025-09-30$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figure1,513Research and development, Q4 FY2025, three months to 2025-12-31$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001193125-26-134813. Derived: 12-month figure less the 9-month figure.Report this figure1,204Research and development, Q1 FY2026, three months to 2026-03-31$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001193125-26-226804.Report this figure1,887Research and development, Q2 FY2026, three months to 2026-06-30$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure
Operating income$k(5,224)Operating income, Q3 FY2023, three months to 2023-09-30−$5.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0000950170-24-127033.Report this figure(5,500)Operating income, Q4 FY2023, three months to 2023-12-31−$5.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-18, accession 0000950170-25-041379. Derived: 12-month figure less the 9-month figure.Report this figure(3,830)Operating income, Q1 FY2024, three months to 2024-03-31−$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0000950170-25-072789.Report this figure(3,071)Operating income, Q2 FY2024, three months to 2024-06-30−$3.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0000950170-25-108894.Report this figure(1,885)Operating income, Q3 FY2024, three months to 2024-09-30−$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figure(2,503)Operating income, Q4 FY2024, three months to 2024-12-31−$2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134813. Derived: 12-month figure less the 9-month figure.Report this figure(2,701)Operating income, Q1 FY2025, three months to 2025-03-31−$2.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-226804.Report this figure(4,052)Operating income, Q2 FY2025, three months to 2025-06-30−$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure(3,184)Operating income, Q3 FY2025, three months to 2025-09-30−$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figure(2,705)Operating income, Q4 FY2025, three months to 2025-12-31−$2.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134813. Derived: 12-month figure less the 9-month figure.Report this figure(2,882)Operating income, Q1 FY2026, three months to 2026-03-31−$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-226804.Report this figure(3,217)Operating income, Q2 FY2026, three months to 2026-06-30−$3.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure
Interest expense$knot reportednot reported(10.0)Interest expense, Q1 FY2024, three months to 2024-03-31−$10.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-15, accession 0000950170-25-072789.Report this figure(26.0)Interest expense, Q2 FY2024, three months to 2024-06-30−$26.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-14, accession 0000950170-25-108894.Report this figure(28.0)Interest expense, Q3 FY2024, three months to 2024-09-30−$28.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figure(30.0)Interest expense, Q4 FY2024, three months to 2024-12-31−$30.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-31, accession 0001193125-26-134813. Derived: 12-month figure less the 9-month figure.Report this figure(29.0)Interest expense, Q1 FY2025, three months to 2025-03-31−$29.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-15, accession 0001193125-26-226804.Report this figure(27.0)Interest expense, Q2 FY2025, three months to 2025-06-30−$27.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure(25.0)Interest expense, Q3 FY2025, three months to 2025-09-30−$25.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figure(29.0)Interest expense, Q4 FY2025, three months to 2025-12-31−$29.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-31, accession 0001193125-26-134813. Derived: 12-month figure less the 9-month figure.Report this figure(4.0)Interest expense, Q1 FY2026, three months to 2026-03-31−$4.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-15, accession 0001193125-26-226804.Report this figure(2.0)Interest expense, Q2 FY2026, three months to 2026-06-30−$2.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure
Net income$k(5,116)Net income, Q3 FY2023, three months to 2023-09-30−$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0000950170-24-127033.Report this figure(5,459)Net income, Q4 FY2023, three months to 2023-12-31−$5.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-18, accession 0000950170-25-041379. Derived: 12-month figure less the 9-month figure.Report this figure(3,813)Net income, Q1 FY2024, three months to 2024-03-31−$3.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figure(2,702)Net income, Q2 FY2024, three months to 2024-06-30−$2.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figure(1,807)Net income, Q3 FY2024, three months to 2024-09-30−$1.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figure(2,463)Net income, Q4 FY2024, three months to 2024-12-31−$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134813. Derived: 12-month figure less the 9-month figure.Report this figure(2,767)Net income, Q1 FY2025, three months to 2025-03-31−$2.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure(4,238)Net income, Q2 FY2025, three months to 2025-06-30−$4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure(2,888)Net income, Q3 FY2025, three months to 2025-09-30−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figure(2,602)Net income, Q4 FY2025, three months to 2025-12-31−$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001193125-26-134813. Derived: 12-month figure less the 9-month figure.Report this figure(2,742)Net income, Q1 FY2026, three months to 2026-03-31−$2.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure(3,128)Net income, Q2 FY2026, three months to 2026-06-30−$3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure
Diluted EPS$ per share(0.15)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0000950170-24-127033.Report this figurenot reported(1.10)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0000950170-25-072789.Report this figure(0.73)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0000950170-25-108894.Report this figure(0.46)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figurenot reported(0.70)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001193125-26-226804.Report this figure(1.06)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure(0.65)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figurenot reported(0.57)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.57 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001193125-26-226804.Report this figure(0.62)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure
Basic EPS$ per share(0.15)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0000950170-24-127033.Report this figurenot reported(1.10)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0000950170-25-072789.Report this figure(0.73)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.73 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0000950170-25-108894.Report this figure(0.46)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figurenot reported(0.70)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001193125-26-226804.Report this figure(1.06)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure(0.65)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.65 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figurenot reported(0.57)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.57 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001193125-26-226804.Report this figure(0.62)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure

Balance sheet

Cash and equivalents$8.8m, Q2 FY2026
Shareholders' equity−$14.0m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m6.4Cash and equivalents, Q3 FY2023, at 2023-09-30$6.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0000950170-23-063851.Report this figure3.4Cash and equivalents, FY2023, at 2023-12-31$3.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-18, accession 0000950170-25-041379.Report this figure5.8Cash and equivalents, Q1 FY2024, at 2024-03-31$5.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0000950170-24-059081.Report this figure9.3Cash and equivalents, Q2 FY2024, at 2024-06-30$9.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-13, accession 0000950170-24-096142.Report this figure6.3Cash and equivalents, Q3 FY2024, at 2024-09-30$6.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0000950170-24-127033.Report this figure4.6Cash and equivalents, FY2024, at 2024-12-31$4.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-31, accession 0001193125-26-134813.Report this figure3.2Cash and equivalents, Q1 FY2025, at 2025-03-31$3.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0000950170-25-072789.Report this figure1.7Cash and equivalents, Q2 FY2025, at 2025-06-30$1.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0000950170-25-108894.Report this figure9.5Cash and equivalents, Q3 FY2025, at 2025-09-30$9.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001193125-26-226804.Report this figure13.4Cash and equivalents, FY2025, at 2025-12-31$13.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure9.5Cash and equivalents, Q1 FY2026, at 2026-03-31$9.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001193125-26-226804.Report this figure8.8Cash and equivalents, Q2 FY2026, at 2026-06-30$8.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure
Current assets$m6.5Current assets, Q3 FY2023, at 2023-09-30$6.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0000950170-23-063851.Report this figure3.6Current assets, FY2023, at 2023-12-31$3.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-18, accession 0000950170-25-041379.Report this figure6.0Current assets, Q1 FY2024, at 2024-03-31$6.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059081.Report this figure9.5Current assets, Q2 FY2024, at 2024-06-30$9.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096142.Report this figure6.6Current assets, Q3 FY2024, at 2024-09-30$6.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-127033.Report this figure5.0Current assets, FY2024, at 2024-12-31$5.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-31, accession 0001193125-26-134813.Report this figure3.6Current assets, Q1 FY2025, at 2025-03-31$3.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-072789.Report this figure2.0Current assets, Q2 FY2025, at 2025-06-30$2.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108894.Report this figure14.5Current assets, Q3 FY2025, at 2025-09-30$14.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figure13.8Current assets, FY2025, at 2025-12-31$13.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure10.0Current assets, Q1 FY2026, at 2026-03-31$10.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001193125-26-226804.Report this figure9.3Current assets, Q2 FY2026, at 2026-06-30$9.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure
Total assets$m7.5Total assets, Q3 FY2023, at 2023-09-30$7.5m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0000950170-23-063851.Report this figure4.6Total assets, FY2023, at 2023-12-31$4.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-18, accession 0000950170-25-041379.Report this figure6.9Total assets, Q1 FY2024, at 2024-03-31$6.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0000950170-24-059081.Report this figure10.3Total assets, Q2 FY2024, at 2024-06-30$10.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0000950170-24-096142.Report this figure7.4Total assets, Q3 FY2024, at 2024-09-30$7.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0000950170-24-127033.Report this figure5.7Total assets, FY2024, at 2024-12-31$5.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-31, accession 0001193125-26-134813.Report this figure4.3Total assets, Q1 FY2025, at 2025-03-31$4.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0000950170-25-072789.Report this figure2.5Total assets, Q2 FY2025, at 2025-06-30$2.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0000950170-25-108894.Report this figure15.0Total assets, Q3 FY2025, at 2025-09-30$15.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figure14.2Total assets, FY2025, at 2025-12-31$14.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure10.4Total assets, Q1 FY2026, at 2026-03-31$10.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001193125-26-226804.Report this figure9.6Total assets, Q2 FY2026, at 2026-06-30$9.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure
Current liabilities$m10.4Current liabilities, Q3 FY2023, at 2023-09-30$10.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0000950170-23-063851.Report this figure11.4Current liabilities, FY2023, at 2023-12-31$11.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-18, accession 0000950170-25-041379.Report this figure11.1Current liabilities, Q1 FY2024, at 2024-03-31$11.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059081.Report this figure10.1Current liabilities, Q2 FY2024, at 2024-06-30$10.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096142.Report this figure7.4Current liabilities, Q3 FY2024, at 2024-09-30$7.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-127033.Report this figure7.0Current liabilities, FY2024, at 2024-12-31$7.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-31, accession 0001193125-26-134813.Report this figure12.1Current liabilities, Q1 FY2025, at 2025-03-31$12.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0000950170-25-072789.Report this figure13.2Current liabilities, Q2 FY2025, at 2025-06-30$13.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108894.Report this figure13.4Current liabilities, Q3 FY2025, at 2025-09-30$13.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figure13.0Current liabilities, FY2025, at 2025-12-31$13.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure7.3Current liabilities, Q1 FY2026, at 2026-03-31$7.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001193125-26-226804.Report this figure7.6Current liabilities, Q2 FY2026, at 2026-06-30$7.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure
Shareholders' equity$m(13.6)Shareholders' equity, Q3 FY2023, at 2023-09-30−$13.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0000950170-24-127033.Report this figure(18.1)Shareholders' equity, FY2023, at 2023-12-31−$18.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-31, accession 0001193125-26-134813.Report this figure(20.3)Shareholders' equity, Q1 FY2024, at 2024-03-31−$20.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figure(16.6)Shareholders' equity, Q2 FY2024, at 2024-06-30−$16.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figure(17.6)Shareholders' equity, Q3 FY2024, at 2024-09-30−$17.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figure(19.6)Shareholders' equity, FY2024, at 2024-12-31−$19.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure(21.8)Shareholders' equity, Q1 FY2025, at 2025-03-31−$21.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure(25.2)Shareholders' equity, Q2 FY2025, at 2025-06-30−$25.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure(13.5)Shareholders' equity, Q3 FY2025, at 2025-09-30−$13.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figure(14.2)Shareholders' equity, FY2025, at 2025-12-31−$14.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure(12.7)Shareholders' equity, Q1 FY2026, at 2026-03-31−$12.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure(14.0)Shareholders' equity, Q2 FY2026, at 2026-06-30−$14.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure

Cash flow

Operating cash flow−$2.1m, Q2 FY2026
Capital expenditure$0, Q4 FY2023
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(4,209)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$4.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0000950170-24-127033. Derived: 9-month figure less the 6-month figure.Report this figure(3,036)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-18, accession 0000950170-25-041379. Derived: 12-month figure less the 9-month figure.Report this figure(2,542)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0000950170-25-072789.Report this figure(2,291)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$2.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0000950170-25-108894. Derived: 6-month figure less the 3-month figure.Report this figure(2,995)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001193125-25-282905. Derived: 9-month figure less the 6-month figure.Report this figure(1,728)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001193125-26-134813. Derived: 12-month figure less the 9-month figure.Report this figure(1,341)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001193125-26-226804.Report this figure(1,569)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349309. Derived: 6-month figure less the 3-month figure.Report this figure(941)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$941.3k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001193125-25-282905. Derived: 9-month figure less the 6-month figure.Report this figure(2,074)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001193125-26-134813. Derived: 12-month figure less the 9-month figure.Report this figure(1,733)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001193125-26-226804.Report this figure(2,083)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349309. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k23.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$23.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0000950170-24-127033. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-18, accession 0000950170-25-041379. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)5.02m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares33.8Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3033,757,164 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0000950170-23-063851.Report this figure34.0Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3133,966,921 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0000950170-24-059081.Report this figure34.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3034,409,064 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0000950170-24-096142.Report this figure34.5Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3034,497,595 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0000950170-24-127033.Report this figure3.5Diluted shares (weighted), Q1 FY2024, three months to 2024-03-313,464,292 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0000950170-25-072789.Report this figure3.7Diluted shares (weighted), Q2 FY2024, three months to 2024-06-303,714,202 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0000950170-25-108894.Report this figure4.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-303,953,370 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figure4.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-313,964,982 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001193125-26-226804.Report this figure4.0Diluted shares (weighted), Q2 FY2025, three months to 2025-06-303,981,992 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure4.4Diluted shares (weighted), Q3 FY2025, three months to 2025-09-304,443,262 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001193125-25-282905.Report this figure4.8Diluted shares (weighted), Q1 FY2026, three months to 2026-03-314,797,833 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001193125-26-226804.Report this figure5.0Diluted shares (weighted), Q2 FY2026, three months to 2026-06-305,023,450 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure

Shares outstanding: 5.10mShares outstanding, period not labelled, at 2026-08-115,103,002 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349309.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.